Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...

Shuttle Pharmaceuticals (NASDAQ: SHPH), a rising force in cancer treatment innovation, has experienced a notable boost in its ...

In a first renal outcome trial of its kind, the SGLT2 inhibitor showed favorable outcomes in the most advanced stages of CKD.

Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of Phase I clinical trial of MRX-5 ...

Long-term treatment with the cell therapy NurOwn was found to significantly extend survival for ALS patients compared with ...

ESSA Pharma has terminated the Phase II clinical trial of masofaniten, a new prostate cancer treatment. Masofaniten, previously known as EPI-7386, is an investigational oral, small-molecule androgen ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

Topline supports moving to Phase 3 trial and shows potential to develop GV1001 as the world's first PSP treatment SEOUL, ...

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ('LakeShore Biopharma' or the 'Company'), a global biopharmaceutical company ...

Akeso begins patient enrollment in phase 3 trial of ivonescimab combination as first-line therapy for biliary tract tumours, compared to durvalumab: China Monday, November 4, 2024 ...

PAR made substantial progress in its Phase 3 clinical trial preparations for the treatment of knee osteoarthritis (OA) with ...